Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis

Peritoneal Dialysis International

Volumn 23, Issue 3, 2003, Pages 267-269

  Araki, Yoshinori ^a,b   Hataya, Hiroshi ^a   Ikeda, Masahiro ^a   Ishikura, Kenji ^a   Honda, Masataka ^a  

^a TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^b HOKKAIDO MEDICAL CENTER   (Japan)

Author keywords

Children; Exit site infection; Intranasal; Mupirocin; Peritonitis; Prophylaxis; Staphylococcus aureus

Indexed keywords

PSEUDOMONIC ACID;

ADOLESCENT; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CARRIER; CHILD; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEVICE REMOVAL; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; INFECTION PREVENTION; JAPAN; MALE; NOSE SMEAR; OINTMENT; PEDIATRIC HOSPITAL; PERITONEAL CATHETER; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0041885461     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300309     Document Type: Article

References (11)

1. Luzar MA. Exit-site infection in continuous ambulatory peritoneal dialysis: a review. Perit Dial Int 1991; 11:333-40.
2. Lye WC, Leong SO, Van der Straten J, Lee ESC. Staphylococcus aureus CAPD-related infections are associated with nasal carriage. Adv Perit Dial 1994; 10:163-5.
3. Wanten CJA, van Oost O, Schneeberger PM, Koolen MI. Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study. Perit Dial Int 1996; 16:352-6.
4. Kingwatanakul P, Warady BA. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. Adv Perit Dial 1997; 13:281-4.
5. Verrina E, Honda M, Warady BA, Piraino B. Prevention of peritonitis in children on peritoneal dialysis. Perit Dial Int 2000; 20:625-30.
6. The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996; 7:2403-8.
7. Mylotte JM, Kahler L, Jackson E. "Pulse" nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis. Infect Control Hosp Epidemiol 1999; 20:741-5.
8. Crabtree JH, Hadnott LL, Burchette RJ, Siddiqi RA. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Adv Perit Dial 2000; 16:271-5.
9. Ritzau J, Hoffman RM, Tzamaloukas AH. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis. Perit Dial Int 2001; 21:471-9.
10. Oh J, Baum H, Klaus G, Schaefer F, European Pediatric Peritoneal Dialysis Study Group. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. Adv Perit Dial 2000; 16:324-7.
11. Schröder CH, Potting CM. Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients and their parents. Perit Dial Int 1998; 18:541-2.